Donor selection in the modern era. - Wikidata - awgldk - TriplyDB

Donor selection in the modern era.

Donor selection in the modern era.

http://www.wikidata.org/entity/Q54936300

about

Donor selection in the modern era.

http://www.wikidata.org/entity/Q54936300

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Donor selection in the modern era.

@en

Donor selection in the modern era.

@nl

type

label

Donor selection in the modern era.

@en

Donor selection in the modern era.

@nl

prefLabel

Donor selection in the modern era.

@en

Donor selection in the modern era.

@nl

P1433

Q54936300-B6810A57-CAEB-4900-ABBF-90F8145508F9

P1476

Q54936300-807399CA-4017-41C8-98FD-5C8E6B728059

P2093

Q54936300-9DE7CD92-60FE-45CE-9051-9B8365CA9017

P2860

Q54936300-0661EDC6-8F0F-4607-8EC4-7C5FC72C89A1

Q54936300-06FFE7C3-2A74-447B-A8F0-96F1B9D09F6F

Q54936300-079B6BC2-B352-420C-A883-9379697693B5

Q54936300-0C5C4DA3-B22A-4125-B576-14E6BD7FB19D

Q54936300-0DA1ECD5-CD3A-4783-9F2D-A2AF891929B7

Q54936300-0FA679A5-9F50-4372-B436-041D46A60A06

Q54936300-1168B495-F368-4E91-BE26-1B4EC657F8E7

Q54936300-12ECA2A9-1C44-45B9-80CA-801E69FF720E

Q54936300-239C6F15-33BB-4C03-9360-30B924811092

Q54936300-29E284D5-B5AF-41A8-83C8-762CDA842998

P304

Q54936300-922E4B17-36D8-4CD5-B54C-99FA0B05C42C

P31

Q54936300-503EB6C8-802E-4588-BCFF-F5E052B58EBD

P356

Q54936300-919F3A05-1570-4E83-B5DC-BF02DCE79C74

P433

Q54936300-CB0E3CFB-C2CF-4EFF-AE7D-BFA134BF53B5

P478

Q54936300-628ECF86-2B8E-4321-A746-7718A5518C08

P577

Q54936300-AE919DE8-5892-48A9-8B8D-C096A4107878

P698

Q54936300-873C6DBE-5FBB-4090-9ECB-F8F8CE5437B8

P932

Q54936300-48776CB0-9CAD-4F15-979C-C376BA7EB59B

P356

P1433

Annals of Cardiothoracic Surgery

P1476

Donor selection in the modern era.

@en

P2093

Kiran K Khush

http://www.w3.org/2001/XMLSchema#string

P2860

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

Long-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registry.

Perfusion preservation versus static preservation for cardiac transplantation: effects on myocardial function and metabolism.

Medium-term outcome of recipients of marginal donor hearts selected with new stress-echocardiographic techniques over standard criteria

The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients.

Association of graft ischemic time with survival after heart transplant among children in the United States.

Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va.

Matching high-risk recipients with marginal donor hearts is a clinically effective strategy.

Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients

P304

126-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/ACS.2017.09.09

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29492390

http://www.w3.org/2001/XMLSchema#string

P932

5827134

http://www.w3.org/2001/XMLSchema#string